0000000000-24-007645.txt : 20241010 0000000000-24-007645.hdr.sgml : 20241010 20240705133603 ACCESSION NUMBER: 0000000000-24-007645 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240705 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: Zenas BioPharma, Inc. CENTRAL INDEX KEY: 0001953926 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD SEC FILE NUMBER: 377-07069 BUSINESS ADDRESS: STREET 1: 1000 WINTER ST, SUITE 1200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-271-2954 MAIL ADDRESS: STREET 1: 1000 WINTER ST, SUITE 1200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Zenas BioPharma (Cayman) Ltd DATE OF NAME CHANGE: 20221108 PUBLIC REFERENCE ACCESSION NUMBER: 0001104659-24-006759 LETTER 1 filename1.pdf begin 644 filename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end TEXT-EXTRACT 2 filename2.txt July 5, 2024 Leon O. Moulder, Jr. Chief Executive Officer Zenas BioPharma, Inc. 1000 Winter Street North Building, Suite 1200 Waltham, MA 02451 Re: Zenas BioPharma, Inc. Amendment No. 3 to Draft Registration Statement on Form S-1 Submitted June 26, 2024 CIK No. 0001953926 Dear Leon O. Moulder Jr.: We have reviewed your amended draft registration statement and have the following comment. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to this letter and your amended draft registration statement or filed registration statement, we may have additional comments. Amendment No. 3 to Draft Registration Statement on Form S-1 Prospectus Summary Overview, page 1 1. We note your disclosure here that obexelimab has the potential to be a "best-in-class" B cell therapy for patients with certain autoimmune diseases. This appears to be speculative given the current development status of your product candidate. Please remove this statement and any other references to obexelimab being potentially "best-in-class" throughout your registration statement. Please contact Li Xiao at 202-551-4391 or Angela Connell at 202-551-3426 if you have questions regarding comments on the financial statements and related matters. Please contact Tyler Howes at 202-551-3370 or Chris Edwards at 202-551-6761 with any other questions. July 5, 2024 Page 2 Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nicholas Roper, Esq.